Search

Vicky Kay Vydra

from Marlboro, NJ
Age ~45
Get Report
Also known as:
Vicky K Vydra, Ydra U Vicky
Related to:
Hannah Miller, 23Shawn P Romanker, 48Jana Vydra, 51Zdena Vydra, 75Renee L Romanker, 46Vaclav VydraJohn P Vydra, 53
Connected to:
Lisa L Vydra, 62Robert Vydra, 47Giridhar Vydyanathan, 53Andrew M Vye, 53Mike H Vye, 73Natalia Vygoder, 60Rudi J Vyhnanek, 77Peter L Vyhovsky, 57Danielle D Vykouk, 35Don C Vymazal, 42

Vicky Vydra Phones & Addresses

  • Marlboro, NJ
  • Fair Lawn, NJ
  • 34 Players Cir, Eatontown, NJ 07724 (732) 380-7089
  • Tinton Falls, NJ
  • Bradley Beach, NJ
  • Keasbey, NJ
  • New Brunswick, NJ

Work

Company: Bristol-myers squibb Feb 2018 Position: Senior manager, integrated laboratory operations, r and d business operations

Education

School / High School: Rutgers University 1997 to 2001

Skills

Synthetic Organic Chemistry • Proficient Communicator • Project Management • Medicinal Chemistry • Drug Development • Drug Discovery • Analytical Chemistry • Biotechnology • Chemistry • Technology Transfer • Lc Ms • R&D

Interests

Skiing • Scuba Diving • New Technologies • Hiking • Camping • Running

Industries

Pharmaceuticals

Resumes

Resumes

Vicky Vydra Photo 1

Senior Manager, Integrated Laboratory Operations, R And D Business Operations

View page
Location:
40 Buttonwood Dr, Marlboro, NJ 07746
Industry:
Pharmaceuticals
Work:
Bristol-Myers Squibb
Senior Manager, Integrated Laboratory Operations, R and D Business Operations
Bristol-Myers Squibb Jul 2011 - Nov 2015
Senior Research Scientist
Bristol-Myers Squibb Jul 2011 - Nov 2015
Senior Manager, Pd Laboratory Infrastructure
Bristol-Myers Squibb Oct 2008 - Jul 2011
Research Scientist Ii
Ol Salty Ii and Double Diamond 1993 - 2010
Diver
Education:
Rutgers University 1997 - 2001
Skills:
Synthetic Organic Chemistry
Proficient Communicator
Project Management
Medicinal Chemistry
Drug Development
Drug Discovery
Analytical Chemistry
Biotechnology
Chemistry
Technology Transfer
Lc Ms
R&D
Interests:
Skiing
Scuba Diving
New Technologies
Hiking
Camping
Running

Publications

Us Patents

Compounds And Methods For Leukotriene Biosynthesis Inhibition

View page
US Patent:
7915298, Mar 29, 2011
Filed:
Sep 24, 2008
Appl. No.:
12/284665
Inventors:
Francis Gosselin - Jersey City NJ, US
Vicky Vydra - Tinton Falls NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/42
A61K 31/352
C07D 271/113
C07D 311/06
US Classification:
514364, 514456, 548143, 549399
Abstract:
This invention provides novel salt and crystalline forms thereof of (−)4-(4-fluorophenyl)-7-[({5-[1-hydroxy-1-(trifluoromethyl)propyl]-1,3,4-oxadiazol-2-yl}amino)-methyl]-2H-chromen-2-one. The compounds are 5-LO inhibitors and are useful for treatment of conditions such as asthma, allergic rhinitis, COPD, and atherosclerosis.

Phosphoric Acid Salt Of A Dipeptidyl Peptidase-Iv Inhibitor

View page
US Patent:
20050032804, Feb 10, 2005
Filed:
Jun 23, 2004
Appl. No.:
10/874992
Inventors:
Stephen Cypes - Santa Clara CA, US
Alex Chen - Metuchen NJ, US
Russell Ferlita - Westfield NJ, US
Karl Hansen - Atlantic Highlands NJ, US
Ivan Lee - Piscataway NJ, US
Vicky Vydra - Fair Lawn NJ, US
Robert Wenslow - East Windsor NJ, US
International Classification:
A61K031/498
C07D487/04
US Classification:
514249000, 544350000
Abstract:
The dihydrogenphosphate salt of 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine is a potent inhibitor of dipeptidyl peptidase-IV and is useful for the prevention and/or treatment of non-insulin dependent diabetes mellitus, also referred to as type 2 diabetes. The invention also relates to a crystalline monohydrate of the dihydrogenphosphate salt as well as a process for its preparation, pharmaceutical compositions containing this novel form and methods of use for the treatment of diabetes, obesity, and high blood pressure.

Novel Crystalline Salts Of A Dipeptidyl Peptidase-Iv Inhibitor

View page
US Patent:
20080227786, Sep 18, 2008
Filed:
Jan 12, 2005
Appl. No.:
10/585603
Inventors:
Russell R. Ferlita - Westfield NJ, US
Karl Hansen - Atlantic Highlands NJ, US
Vicky K. Vydra - Fair Lawn NJ, US
Yaling Wang - Westfield NJ, US
Christopher M. Lindemann - Loveland CO, US
International Classification:
A61K 31/4985
C07D 487/02
A61P 3/10
US Classification:
514249, 544350
Abstract:
Novel crystalline salts of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-&agr; amine are potent inhibitors of dipeptidyl peptidase-IV and are useful for the treatment of non-insulin dependent (Type 2) diabetes mellitus. The invention also relates to pharmaceutical compositions containing these novel salts, processes to prepare these salts and their pharmaceutical compositions as well as uses thereof for the treatment of Type 2 diabetes.

Synthesis And Crystalline Forms Of Cb-1 Antagonist/Inverse Agonist

View page
US Patent:
20100292282, Nov 18, 2010
Filed:
Oct 20, 2008
Appl. No.:
12/681797
Inventors:
Kevin R. Campos - Berkeley Heights NJ, US
Cheng-Yi Chen - Plainsboro NJ, US
Jennifer R. Foley - Garwood NJ, US
Michael Hillier - Libertyville IL, US
Wendy S. Jen - Fanwood NJ, US
Amude M. Kassim - Monmouth Junction NJ, US
Artis Klapars - Edison NJ, US
Andrey V. Peresypkin - Cambridge MA, US
Thorsten Rosner - Berkeley Heights NJ, US
Cecile G. Savarin - Newbury Park CA, US
Matthew Tudge - Chatham NJ, US
Narayan Variankaval - Plainsboro NJ, US
Vicky Vydra - Tinton Falls NJ, US
Dalian Zhao - Fanwood NJ, US
International Classification:
A61K 31/4245
C07D 413/10
C07D 271/113
C07C 255/53
A61P 3/04
A61P 3/10
A61P 25/28
US Classification:
514364, 548144, 558423
Abstract:
The present invention relates to a process for producing crystalline 3-[(1S)-1-(1-{(S)-(4-chlorophenyl)[3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methyl-propyl]-5-fluorobenzonitrile, and novel salts, solvates, hydrates and polymorphs thereof.
Control profile
Vicky Kay Vydra from Marlboro, NJ, age ~45 Get Report